ASPG and acute lymphoblastic leukemia: This metabolic dependency can be targeted therapeutically using L-asparaginase (ASNase from E. coli), which is deployed in the clinical management of acute lymphoblastic leukemia (ALL) (Batool et al., 2016), and catalyzes the conversion of asparagine to aspartic acid and ammonia (Chan et al., 2019).